Researchers from the MassGeneral Institute for Neurodegenerative Diseases (MIND) detailed some of the latest advances in brain disease research at MIND’s 2018 Visiting Day.
A grateful stroke patient from Methuen, Massachusetts says the swift work of his expert Mass General care team allowed him to return home to enjoy his family, including a new granddaughter.
A Mass General researcher is studying a rare, inherited form of ALS, aiming to diagnose the disease in its earliest stages and develop new treatments.
A clinician-investigator from Mass General’s Multiple Sclerosis Clinic discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.
At Mass General, Scott Plotkin, MD, PhD, and Vijaya Ramesh, PhD, are using their respective expertise in clinical and fundamental science to investigate new treatments for neurofibromatosis and two related disorders.
Donor commitment allows rare disease research breakthrough, providing insights into Parkinson’s and other movement disorder diseases.
Genetic insights into rare diseases and new models of collaborative research that involve patients, clinicians, scientists and members of industry could produce much-needed new treatments.
Mass General researchers have developed a forecasting model for predicting future migraine attacks based on current levels of stress and head pain.
Invented at Mass General, a technology called fMRI continues to have a revolutionary impact on brain science and patient care.
Mass General ALS experts believe the new ALS House Call Program will help to change the course of medical care planning and improve outcomes for people with amyotrophic lateral sclerosis.